271 related articles for article (PubMed ID: 33430758)
1. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V
Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758
[TBL] [Abstract][Full Text] [Related]
2. Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with
Kostelnik TI; Olson AP; Grundmane A; Ellison PA; Mynerich J; Chen S; Marinova A; Randhawa P; Karaivanov D; Aluicio-Sarduy E; Barnhart TE; Orvig C; Ramogida CF; Hoehr C; Filosofov D; Engle JW; Radchenko V
Nucl Med Biol; 2023; 122-123():108352. PubMed ID: 37390607
[TBL] [Abstract][Full Text] [Related]
3. Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations.
Filosofov D; Kurakina E; Radchenko V
Nucl Med Biol; 2021; 94-95():1-19. PubMed ID: 33461040
[TBL] [Abstract][Full Text] [Related]
4. 119Sb--a potent Auger emitter for targeted radionuclide therapy.
Thisgaard H; Jensen M
Med Phys; 2008 Sep; 35(9):3839-46. PubMed ID: 18841834
[TBL] [Abstract][Full Text] [Related]
5. Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of
Fiaccabrino DE; Kunz P; Radchenko V
Nucl Med Biol; 2021; 94-95():81-91. PubMed ID: 33607326
[TBL] [Abstract][Full Text] [Related]
6. Low-energy electron emitters for targeted radiotherapy of small tumours.
Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
[TBL] [Abstract][Full Text] [Related]
7. The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications.
Radchenko V; Schaffer P; Knapp FFR
Curr Radiopharm; 2018; 11(3):154-155. PubMed ID: 30378473
[No Abstract] [Full Text] [Related]
8. Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron.
Thisgaard H; Jensen M
Appl Radiat Isot; 2009 Jan; 67(1):34-8. PubMed ID: 18990581
[TBL] [Abstract][Full Text] [Related]
9. Selective Chelation of the Exotic Meitner-Auger Emitter Mercury-197 m/g with Sulfur-Rich Macrocyclic Ligands: Towards the Future of Theranostic Radiopharmaceuticals.
Randhawa P; Gower-Fry KL; Stienstra CMK; Tosato M; Chen S; Gao Y; McDonagh AW; Di Marco V; Radchenko V; Schreckenbach G; Ramogida CF
Chemistry; 2023 Apr; 29(21):e202203815. PubMed ID: 36701527
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Radiometals Beyond
Müller C; van der Meulen NP; Benešová M; Schibli R
J Nucl Med; 2017 Sep; 58(Suppl 2):91S-96S. PubMed ID: 28864619
[TBL] [Abstract][Full Text] [Related]
11. Production of Copper Radionuclides in Compact Medical Cyclotrons using Solid Targets.
Avila-Rodriguez MA; Valdovinos HF
Curr Radiopharm; 2021; 14(4):340-353. PubMed ID: 32981514
[TBL] [Abstract][Full Text] [Related]
12. Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy.
Nelson BJB; Andersson JD; Wuest F
Nucl Med Biol; 2022; 110-111():59-66. PubMed ID: 35487834
[TBL] [Abstract][Full Text] [Related]
13. Production and radiochemical separation of the Auger electron emitter 140Nd.
Rösch F; Brockmann J; Lebedev NA; Qaim SM
Acta Oncol; 2000; 39(6):727-30. PubMed ID: 11130011
[TBL] [Abstract][Full Text] [Related]
14.
Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
[TBL] [Abstract][Full Text] [Related]
15. Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47.
Chernysheva M; Loveless SC; Brossard T; Becker K; Cingoranelli S; Aluicio-Sarduy E; Song J; Ellison P; Nolen J; Rotsch DA; Lapi SE; Engle JW
Curr Radiopharm; 2021; 14(4):359-373. PubMed ID: 33438551
[TBL] [Abstract][Full Text] [Related]
16. High Separation Factor, High Molar Activity, and Inexpensive Purification Method for the Production of Pure
Saghez BS; Yang H; Radchenko V
Inorg Chem; 2024 Mar; 63(12):5330-5340. PubMed ID: 38324916
[No Abstract] [Full Text] [Related]
17. Development of novel radionuclides for medical applications.
Qaim SM; Spahn I
J Labelled Comp Radiopharm; 2018 Mar; 61(3):126-140. PubMed ID: 29110328
[TBL] [Abstract][Full Text] [Related]
18. Targeting the nucleus: an overview of Auger-electron radionuclide therapy.
Cornelissen B; Vallis KA
Curr Drug Discov Technol; 2010 Dec; 7(4):263-79. PubMed ID: 21034408
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
20. Status and future perspectives of Meitner-Auger and low energy electron-emitting radionuclides for targeted radionuclide therapy.
Radchenko V; Engle JW; Thisgaard H
Nucl Med Biol; 2021; 94-95():106. PubMed ID: 33647567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
